- Investing Ideas
- /
- U.S. Healthcare Large Cap High Growth Potential
U.S. Healthcare Large Cap High Growth Potential
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
21 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GDRXGoodRx Holdings | US$44.29 | 5.2% | n/a | US$17.5b | US$43.07 | P/S27.8x | E48.9% | n/a | ||
| NVCRNovoCure | US$126.83 | -8.5% | 16.4% | US$13.1b | US$176.50 | P/S24.1x | E79.8% | n/a | ||
| AGLagilon health | US$31.02 | -1.6% | n/a | US$12.1b | US$42.86 | P/S7.8x | E74.1% | n/a | ||
| TDOCTeladoc Health | US$133.96 | -5.9% | -32.8% | US$21.3b | US$197.65 | P/S13.1x | E57.8% | n/a | ||
| ALGNAlign Technology | US$710.31 | -2.2% | 116.5% | US$56.1b | US$712.93 | P/E80.4x | E22.2% | n/a | ||
| DOCSDoximity | US$94.29 | -6.9% | n/a | US$17.5b | US$63.50 | P/E542.1x | E24.9% | n/a | ||
| MCKMcKesson | US$208.66 | 2.0% | 37.7% | US$32.3b | US$239.31 | P/E-7.2x | E28.0% | 0.9% | ||
| ABCAmerisourceBergen | US$125.80 | 1.8% | 29.9% | US$26.1b | US$141.00 | P/B688.6x | E23.6% | 1.4% | ||
| SYKStryker | US$277.10 | 0.06% | 31.0% | US$104.5b | US$284.12 | P/E50.2x | E23.0% | 0.9% | ||
| PODDInsulet | US$291.44 | -3.6% | 30.3% | US$20.1b | US$285.37 | P/S20.2x | E49.5% | n/a | ||
| DXCMDexCom | US$551.67 | -0.2% | 42.8% | US$53.4b | US$514.19 | P/E100.6x | E23.4% | n/a | ||
| ABMDAbiomed | US$355.18 | -2.9% | 28.6% | US$16.1b | US$387.33 | P/E104.4x | E31.0% | n/a | ||
| VEEVVeeva Systems | US$299.74 | -2.1% | 13.9% | US$46.0b | US$341.52 | P/E108.4x | E18.7% | n/a | ||
| PENPenumbra | US$288.88 | 6.4% | 45.0% | US$10.6b | US$323.43 | P/E664.6x | E53.9% | n/a | ||
| TFXTeleflex | US$388.67 | 0.8% | 12.1% | US$18.2b | US$439.25 | P/E51.8x | E23.4% | 0.3% | ||
| BSXBoston Scientific | US$45.01 | -0.9% | 13.5% | US$64.1b | US$50.62 | P/E121.8x | E38.8% | n/a | ||
| MOHMolina Healthcare | US$266.11 | 2.9% | 46.8% | US$15.5b | US$281.62 | P/E24.6x | E19.0% | n/a | ||
| CNCCentene | US$61.63 | -0.5% | 2.0% | US$35.9b | US$84.58 | P/E49.9x | E42.0% | n/a | ||
| RMDResMed | US$290.42 | -1.7% | 68.0% | US$42.3b | US$260.00 | P/E89.2x | E18.1% | 0.6% | ||
| EWEdwards Lifesciences | US$121.02 | -0.9% | 44.6% | US$75.4b | US$117.83 | P/E51.6x | E8.8% | n/a | ||
| CERNCerner | US$74.23 | -1.1% | 3.4% | US$21.9b | US$83.78 | P/E31.2x | E15.9% | 1.2% |
Page 1 of 1